PAVmed (PAVM) FCF Margin (2021 - 2025)
PAVmed's (PAVM) quarterly FCF Margin came in at 1869.14% in Q4 2025, down 276914.0% year-on-year from N/an in Q4 2024, and up 89.65% quarter-over-quarter from 18060.0% in Q3 2025.
PAVmed (PAVM) FCF Margin (2021 - 2025) Analysis & Trends
PAVmed's FCF Margin history runs 5 years deep, the most recent figure standing at 1869.14% for Q4 2025.
- On a quarterly basis, FCF Margin fell 276914.0% year-over-year to 1869.14% in Q4 2025; TTM through Dec 2025 was 5231.0%, a 441998.0% decrease from a year earlier, with the FY2025 full-year figure at 5231.0%, down 410883.0% from the prior year.
- FCF Margin climbed to 1869.14% in Q4 2025 per PAVM's latest filing, from 18060.0% in the prior quarter.
- Across five years, FCF Margin topped out at 900.0% in Q4 2024 and bottomed at 25864.47% in Q3 2022.
- The 5-year median for FCF Margin is 5022.25% (2021), against an average of 8355.72%.
- Across the five-year window, FCF Margin plunged 2183797 bps in 2022 and soared 2446030 bps in 2023, its largest moves.
- Year by year, FCF Margin stood at 6018.0% in 2021, then sank by 154 bps to 15286.61% in 2022, then surged by 92 bps to 1149.38% in 2023, then surged by 178 bps to 900.0% in 2024, then tumbled by 308 bps to 1869.14% in 2025.
- Per Business Quant, the three latest PAVM FCF Margin figures stand at 1869.14% (Q4 2025), 18060.0% (Q3 2025), and 20450.0% (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 8.20% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.89% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 21.26% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 3.29% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -1.28% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 37.67% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.68% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.18% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | PAVmed | 9.85 Mn | -3.35 Mn | -4,000.00 | -1,869.14% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1,869.14% |
| Sep 30, 2025 | -18,060.00% |
| Jun 30, 2025 | -20,450.00% |
| Mar 31, 2025 | -19,837.50% |
| Dec 31, 2024 | 900.00% |
| Jun 30, 2024 | -1,190.91% |
| Mar 31, 2024 | -1,302.08% |
| Dec 31, 2023 | -1,149.38% |
| Sep 30, 2023 | -1,404.17% |
| Jun 30, 2023 | -7,666.27% |
| Mar 31, 2023 | -3,674.44% |
| Dec 31, 2022 | -15,286.61% |
| Sep 30, 2022 | -25,864.47% |
| Mar 31, 2022 | -6,792.06% |
| Dec 31, 2021 | -6,018.00% |
| Sep 30, 2021 | -4,026.50% |